Literature DB >> 7826140

Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity.

D J Taylor1, N T Cheung, P T Dawes.   

Abstract

OBJECTIVE: To investigate if the increased concentrations of stromelysin (MMP-3) found in the synovial fluid (SF) of patients with various arthritides reflect the concentrations in the circulation.
METHODS: Using a double antibody ELISA, we have measured proMMP-3 concentrations in sera from these patient groups and in others with a heightened acute phase response (APR) as a result of multiple organ failure.
RESULTS: The median serum concentration of proMMP-3 was increased by up to ninefold in the inflammatory arthritides, but not in osteoarthritis or in patients with a heightened APR resulting from a non-chronic inflammatory condition.
CONCLUSION: In chronic inflammatory diseases such as rheumatoid arthritis, serum proMMP-3 may prove to be a more specific indicator of monokine activity than currently available serum markers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826140      PMCID: PMC1005460          DOI: 10.1136/ard.53.11.768

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

Authors:  Y Okada; T Morodomi; J J Enghild; K Suzuki; A Yasui; I Nakanishi; G Salvesen; H Nagase
Journal:  Eur J Biochem       Date:  1990-12-27

2.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.

Authors:  Y Okada; H Nagase; E D Harris
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

Review 3.  Metalloproteinases and their inhibitors in matrix remodeling.

Authors:  L M Matrisian
Journal:  Trends Genet       Date:  1990-04       Impact factor: 11.639

Review 4.  Stimulation of hepatic acute phase response by cytokines and glucocorticoids.

Authors:  H Baumann; K R Prowse; S Marinković; K A Won; G P Jahreis
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

5.  Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis.

Authors:  R L Goldberg; J P Huff; M E Lenz; P Glickman; R Katz; E J Thonar
Journal:  Arthritis Rheum       Date:  1991-07

6.  Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression.

Authors:  K L MacNaul; N Chartrain; M Lark; M J Tocci; N I Hutchinson
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

7.  Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis.

Authors:  S Sasaki; H Iwata; N Ishiguro; K Obata; T Miura
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

8.  Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines.

Authors:  E N Unemori; M S Hibbs; E P Amento
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.

Authors:  L A Walakovits; V L Moore; N Bhardwaj; G S Gallick; M W Lark
Journal:  Arthritis Rheum       Date:  1992-01

10.  Elevated levels of plasma hyaluronan in septicaemia.

Authors:  S Berg; B Brodin; F Hesselvik; T C Laurent; R Maller
Journal:  Scand J Clin Lab Invest       Date:  1988-12       Impact factor: 1.713

View more
  10 in total

1.  Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.

Authors:  C Ribbens; M Martin y Porras; N Franchimont; M-J Kaiser; J-M Jaspar; P Damas; F A Houssiau; M G Malaise
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

2.  Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions.

Authors:  N J Zvaifler; V Tsai; S Alsalameh; J von Kempis; G S Firestein; M Lotz
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

3.  Intra-articular injection of hyaluronate and indomethacin in rabbits with antigen-induced arthritis.

Authors:  Yow-Jen Lo; Ming-Thau Sheu; Wen-Chi Tsai; Yun-Ho Lin; Jau-Le Li; Yu-Chih Liang; Chi-Ching Chang; Ming-Shium Hsieh; Chien-Ho Chen
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

4.  Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.

Authors:  Eiman Soliman; W Labib; G el-Tantawi; A Hamimy; A Alhadidy; A Aldawoudy
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

5.  Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.

Authors:  A A den Broeder; L A B Joosten; T Saxne; D Heinegård; H Fenner; A M M Miltenburg; W L H Frasa; L J van Tits; W A Buurman; P L C M van Riel; L B A van de Putte; P Barrera
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

6.  The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.

Authors:  Nicodemus Tedla; Kathryn Gibson; H Patrick McNeil; David Cosman; Luis Borges; Jonathan P Arm
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture.

Authors:  P E Lazzerini; P L Capecchi; F Nerucci; A Fioravanti; F Chellini; M Piccini; S Bisogno; R Marcolongo; F Laghi Pasini
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

8.  Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-1β.

Authors:  Joseph F Baker; Pauline M Walsh; Damien P Byrne; Kevin J Mulhall
Journal:  J Orthop Traumatol       Date:  2012-06-09

9.  Serum pro-matrix metalloproteinase-3 as an indicator of disease activity and severity in rheumatoid arthritis: comparison with traditional markers.

Authors:  Aşkin Ateş; Nuran Türkçapar; Umit Olmez; Olcay Tiryaki; Nurşen Düzgün; Emre Uğuz; Murat Duman
Journal:  Rheumatol Int       Date:  2007-04-11       Impact factor: 3.580

10.  Alteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis.

Authors:  Masaru Takeshita; Atsushi Kuno; Katsuya Suzuki; Atsushi Matsuda; Hiroko Shimazaki; Tomomi Nakagawa; Yuki Otomo; Yasuaki Kabe; Makoto Suematsu; Hisashi Narimatsu; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2016-05-21       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.